Trained Navigators Help Patients With Kidney Transplant Process

This article originally appeared here.
Share this content:
Trained Navigators Help Patients With Kidney Transplant Process
Trained Navigators Help Patients With Kidney Transplant Process

MONDAY, March 26, 2018 (HealthDay News) -- A trained patient navigator helps to increase access to the transplant waitlist for disadvantaged patients with kidney failure who need a longer time to get through the transplant evaluation process, according to a study published online March 26 in the Clinical Journal of the American Society of Nephrology.

Mohua Basu, M.P.H., from Emory University in Atlanta, and colleagues randomized 401 patients referred for kidney transplant evaluation (January 2013 to August 2014, and followed through May 2016) at a single center to either a trained navigator-assisted intervention or regular care.

The researchers found that waitlisting was not significantly different among intervention and control patients overall (P = 0.17). Time from referral to waitlisting was 126 days longer for intervention patients. While there was no difference in waitlisting in the early period between intervention and control patients (hazard ratio, 1.03; 95 percent confidence interval, 0.69 to 1.53), intervention patients were 3.3 times more likely to be waitlisted after 500 days (hazard ratio, 3.31; 95 percent confidence interval, 1.20 to 9.12). There was no association between use of the navigator and starting the evaluation (85 versus 79 percent; P = 0.11) or completing the evaluation (58 versus 51 percent; P = 0.14), but intervention patients had more living donor inquiries (18 versus 10 percent; P = 0.03).

"A transplant center-based navigator targeting disadvantaged patients improved waitlisting, but not until after 500 days of follow-up," the authors write. "However, the absolute impact was relatively small."

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

8 More U.S. Communities to Be Assessed for PFAS Toxin Exposure

8 More U.S. Communities to Be Assessed for ...

Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

FDA Advances Regulation to Ensure Sunscreen Safety, Efficacy

Proposed rule will help consumers better understand what the sunscreens they are buying can actually do

U.S. Agencies Probing Johnson  Johnson Over Asbestos in Talc

U.S. Agencies Probing Johnson & Johnson Over Asbestos ...

Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma

is free, fast, and customized just for you!




Already a member?

Sign In Now »